EUVIMEDEUVIMED entdecken
Crossref

Extra villous trophoblast-derived PDL1 can ameliorate macrophage inflammation and promote immune adaptation associated with preeclampsia

Yutong Cui, Suwen Wu, Ketong Liu, Huanqiang Zhao, Bo Ma, Lili Gong, Qiongjie Zhou, Xiaotian Li

Journal of Reproductive Immunology · 2024

DOI: 10.1016/j.jri.2023.104186 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Reproductive Immunology, 2024. Verfasst von Yutong Cui und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department Obstetrics, Obstetrics and Gynaecology Hospital of Fudan University, Shanghai, China. Hauptthemen laut MEDLINE: Pre-Eclampsia. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 68 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION: Severe preeclampsia (sPE) is a systemic syndrome that may originate from chronic inflammation. Maintaining maternal-fetal hemostasis by the co-inhibitory molecule programmed death ligand 1 (PDL1) can be favorable for ameliorating inflammation from immune cells. Apart from programmed death 1 (PD1) expression, decidual macrophages (dMs) produce inflammatory cytokines, in response to cells which express PDL1. However, strong evidence is lacking regarding whether the PDL1/PD1 interaction between trophoblasts and decidual macrophages affects inflammation during sPE development. METHODS: To determine whether the trophoblast-macrophage crosstalk via the PDL1/PD1 axis modulates the inflammatory response in sPE-like conditions, at first, maternal-fetal tissues from sPE and normal patients were collected, and the PDL1/PD1 distribution was analyzed by Western blot, immunohistochemistry/ immunofluorescence and flow cytometry. Next, a coculture system was established and flow cytometry was used to identify how PDL1 was involved in macrophage-related inflammation under hypoxic stress. Transcriptional analysis was performed to clarify the inflammation-associated pathway induced by the PDL1/PD1 interaction. Finally, the Nω-nitro-L-arginine methyl ester hydrochloride (L-NAME) mouse model was used to examine the effect of PDL1 on macrophage-related inflammation by measuring PE-like symptoms. RESULTS: In maternal-fetal tissue from sPE patients, placental extravillous trophoblasts (EVTs) and dMs had a surprisingly increase of PDL1 and PD1 expression, respectively, accompanied by a higher percentage of CD68 +CD86 + dMs. In vitro experiments showed that trophoblast-derived PDL1 under hypoxia interacted with PD1 on CD14 +CD80 +macrophages, leading to suppression of inflammation through the TNFα-p38/NFκB pathway. Accordingly, the PE-like mouse model showed a reversal of PE-like symptoms and a reduced F4/80 + CD86 + macrophage percentage in the uterus in response to recombinant PDL1 protein administration, indicating the protective effect of PDL1. DISCUSSION: Our results initially explained an immunological adaptation of trophoblasts under placental hypoxia, although this protection was insufficient. Our findings suggest the possible capacity of modulating PDL1 expression as a potential therapeutic strategy to target the inflammatory response in sPE.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pre-EclampsiaAnimalsFemaleHumansMicePregnancyB7-H1 AntigenDisease Models, AnimalHypoxiaInflammationMacrophagesPlacentaTrophoblasts

Stichwörter der Autor:innen

AdaptationInflammationMaternal-fetal interactionPDL1Preeclampsia

Substanzen

B7-H1 AntigenCD274 protein, humanCd274 protein, mouse

Autor:innen und Institutionen

  • Department Obstetrics, Obstetrics and Gynaecology Hospital of Fudan University, Shanghai, China.
  • Department of Obstetrics, Shenzhen Maternity and Child Healthcare Hospital, Shenzhen, Guangdong, China.
  • Department Obstetrics, Obstetrics and Gynaecology Hospital of Fudan University, Shanghai, China; Shanghai Key Laboratory of Female Reproductive Endocrine-Related Diseases, Fudan University, Shanghai, China. Electronic a…
  • Department Obstetrics, Obstetrics and Gynaecology Hospital of Fudan University, Shanghai, China; Department of Obstetrics, Shenzhen Maternity and Child Healthcare Hospital, Shenzhen, Guangdong, China. Electronic address…

Zitieren

APA

Cui, Y., Wu, S., Liu, K., Zhao, H., Ma, B., Gong, L., Zhou, Q., & Li, X. (2024). Extra villous trophoblast-derived PDL1 can ameliorate macrophage inflammation and promote immune adaptation associated with preeclampsia. Journal of Reproductive Immunology. https://doi.org/10.1016/j.jri.2023.104186

Vancouver

Cui Y, Wu S, Liu K, Zhao H, Ma B, Gong L, et al. Extra villous trophoblast-derived PDL1 can ameliorate macrophage inflammation and promote immune adaptation associated with preeclampsia. Journal of Reproductive Immunology. 2024. doi:10.1016/j.jri.2023.104186

BibTeX
@article{Cui2024,
  author = {Cui, Yutong and Wu, Suwen and Liu, Ketong and Zhao, Huanqiang and Ma, Bo and Gong, Lili and Zhou, Qiongjie and Li, Xiaotian},
  title = {Extra villous trophoblast-derived PDL1 can ameliorate macrophage inflammation and promote immune adaptation associated with preeclampsia},
  journal = {Journal of Reproductive Immunology},
  year = {2024},
  doi = {10.1016/j.jri.2023.104186}
}
Kostenlos starten →